Article Data

  • Views 903
  • Dowloads 158

Original Research

Open Access

Prevalence of erectile dysfunction among smokers in southwestern Saudi Arabia

  • Abdulaziz A. Alamri1,§
  • Faisal Saeed Al-Qahtani1
  • Awad Saeed Alsamghan2
  • Faisal Saeed Alahmari3,†
  • Saad Abdullah Alahmari3,†
  • Naif Murayh alsharif3,†
  • Abdulelah Mohammed Aljamaan3,†
  • Abdulaziz Baazeem4

1Department of Surgery, College of Medicine, King Khalid University, 62529 Abha, Saudi Arabia

2Department of Family and Community Medicine, College of Medicine, King Khalid University, 62529 Abha, Saudi Arabia

3College of Medicine, King Khalid University, 62529 Abha, Saudi Arabia

4Department of Surgery, College of Medicine, Umm Al-Qura University, 24382 Makkah al-Mukarramah, Saudi Arabia

DOI: 10.31083/j.jomh1804092 Vol.18,Issue 4,April 2022 pp.1-4

Submitted: 18 September 2021 Accepted: 17 December 2021

Published: 30 April 2022

† These authors contributed equally.

§ The author’s own special request.


Background: Erectile dysfunction (ED) is the failure to develop or maintain erections that are adequate for sexual performance. ED is increasing in prevalence and incidence worldwide. According to the latest epidemiologic studies, around 10% of men aged 40 to 70 have severe or complete ED. An additional 25% of men in this age group have moderate or sporadic ED. The literature is replete with evidence that smoking has a negative impact on erectile function independent of age or comorbidities. Methods: This cross-sectional study was conducted in the southwestern region of Saudi Arabia, from March-2021 to June-2021. Data on demographic characteristics, erectile dysfunction, and smoking habits was collected by self-administered questionnaire. The descriptive statistics were calculated to measure significant differences among variables, and the chi-square test and t-test were used at 5% level of significance. The data analysis was done by using Statistical Package for Social Sciences (SPSS)-version 20 software (IBM Corp., Armonk, NY, USA). Results: Out of 500 distributed questionnaires, 450 questionnaires were returned, yielding a response rate of 90.0%. Of 450 patients, the average (SD) age was 33.6 (8.9) years and 55.6% were sexually active (N = 250). Thirty six percent of sexually active respondents were smokers. Independent of age, smokers were at higher risk of having ED. Conclusions: Smoking was associated with higher risk of ED. So, health-policy makers should start an awareness campaign to educate people about the adverse effects of smoking on men’s health. The government should also support these programs for the public.


erectile; dysfunction; smoking; men; diseases

Cite and Share

Abdulaziz A. Alamri,Faisal Saeed Al-Qahtani,Awad Saeed Alsamghan,Faisal Saeed Alahmari,Saad Abdullah Alahmari,Naif Murayh alsharif,Abdulelah Mohammed Aljamaan,Abdulaziz Baazeem. Prevalence of erectile dysfunction among smokers in southwestern Saudi Arabia. Journal of Men's Health. 2022. 18(4);1-4.


[1] Ni H, Coady S, Rosamond W, Folsom AR, Chambless L, Rus-sell SD, et al. Trends from 1987 to 2004 in sudden death due to coronary heart disease: the Atherosclerosis Risk in Communi-ties (ARIC) study. American Heart Journal. 2009; 157: 46–52.

[2] Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997; 349: 1498–1504.

[3] Kappetein AP, Head SJ, Morice MC, Banning AP, Serruys PW, Mohr FW, et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. European Journal of Cardio-Thoracic Surgery. 2013; 43: 1006–1013.

[4] Kappetein AP, Dawkins KD, Mohr FW, Morice MC, Mack MJ, Russell ME, et al. Current percutaneous coronary inter-vention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. European Journal of Cardio-Thoracic Surgery. 2006; 29: 486–491.

[5] NIH Consensus Conference Impotence. NIH Consensus Devel-opment Panel on Impotence. JAMA. 1993; 270: 83–90.

[6] Prins J, Blanker MH, Bohnen AM, Thomas S, Bosch JLHR. Prevalence of erectile dysfunction: a systematic review of population-based studies. International Journal of Impotence Research. 2002; 14: 422–432.

[7] Reriani M, Flammer AJ, Li J, Prasad M, Rihal C, Prasad A, et al. Microvascular endothelial dysfunction predicts the develop-ment of erectile dysfunction in men with coronary atherosclero-sis without critical stenoses. Coronary Artery Disease. 2014; 25: 552–557.

[8] Rosen R, Cappelleri J, Smith M, Lipsky J, Peña B. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erec-tile dysfunction. International Journal of Impotence Research. 1999; 11: 319–326.

[9] Chew KK, Finn J, Stuckey B, Gibson N, Sanfilippo F, Bremner A, et al. K. Erectile dysfunction as a predictor for subsequente atherosclerotic cardiovascular events: findings from a linked-data study. The Journal of Sexual Medicine. 2010; 7: 192–202.

[10] Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moin-pour CM, Coltman CA. Erectile dysfunction and subsequent car-diovascular disease. JAMA. 2005; 294: 2996–3002.

[11] Greenstein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z. Does severity of ischemic coronary disease correlate with erec-tile function? International Journal of Impotence Research. 1997; 9: 123–126.

[12] Canat L, Cicek G, Atis G, Gurbuz C, Caskurlu T. Is there a rela-tionship between severity of coronary artery disease and severity of erectile dysfunction? International Brazilian Journal of Urol-ogy. 2013; 39: 465–473.

[13] Foroutan SK, Rajabi M. Erectile dysfunction in men with angio-graphically documented coronary artery disease. Urology Jour-nal. 2007; 4: 28–32.

[14] Montorsi P, Ravagnani PM, Galli S, Rotatori F, Veglia F, Briganti A, et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. European Heart Journal. 2006; 27: 2632–2639.

[15] Serruys PW, Morice M, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. New England Journal of Medicine. 2009; 360: 961–972.

[16] Farooq V, Head SJ, Kappetein AP, Serruys PW. Widening clini-cal applications of vthe SYNTAX Score. Heart. 2014; 100: 276–287.

[17] Rhoden EL, Telöken C, Sogari PR, Vargas Souto CA. The use of the simplified International Index of Erectile Function (IIEF- 5) as a diagnostic tool to study the prevalence of erectile dys-function. International Journal of Impotence Research. 2002; 14: 245–250.

[18] Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Mac-chi A, et al. Erectile Dysfunction Prevalence, Time of Onset and Association with Risk Factors in 300 Consecutive Patients with Acute Chest Pain and Angiographically Documented Coronary Artery Disease. European Urology. 2003; 44: 360–365.

[19] Australian Institute of Health and Welfare Statistics on drug use in Australia 2004. AIHW Cat. No. PHE 62 (Drug Statistics Se-ries No. 15). Canberra: AIHW. 2005.

[20] New South Wales Department of Health. New South Wales Adult Health Survey 2003. N S W Public Health Bull. 2004.

[21] Tomlinson J. ABC of sexual health: taking a sexual history. BMJ. 1998; 317: 1573–1576.

[22] Action on S m o k i n, Health (ASH) U K. Smoking and erectile dysfunction in men. Available at: /html/impotent.html (Accessed: 25 May 2005).

[23] DAVIS RM. The Marlboro Man needs Viagra. Tobacco Control. 1998; 7: 227–227.

[24] Tobacco Control Supersite Picture gallery ‐ graphical cigarette pack health warnings. Available at: (Accessed: 21 December 2005).

[25] Tengs TO, Osgood ND. The Link between Smoking and Impo-tence: Two Decades of Evidence. Preventive Medicine. 2001; 32: 447–452.

[26] McVARY KT, CARRIER S, WESSELLS H. SMOKING and ERECTILE DYSFUNCTION. The Journal of Urology. 2001; 166: 1624–1632.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.

SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)

Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.

Scopus: CiteScore 0.9 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (

Submission Turnaround Time